Your browser doesn't support javascript.
loading
Evaluación positiva de medicamentos: 4.º Trimestre 2012 / Positive assessment of drugs: 4th quarter 2012
Puerro Vicente, M; García Luque, A; Prats Olivan, P; González Alfonso, M.
Affiliation
  • Puerro Vicente, M; Hospital Central de la Defensa Gómez Ulla. Servicio de Farmacología Clínica. Madrid. España
  • García Luque, A; Hospital Central de la Defensa Gómez Ulla. Servicio de Farmacología Clínica. Madrid. España
  • Prats Olivan, P; Hospital Central de la Defensa Gómez Ulla. Servicio de Farmacía Hospitalaria. Madrid. España
  • González Alfonso, M; Hospital Central de la Defensa Gómez Ulla. Servicio de Farmacía Hospitalaria. Madrid. España
Sanid. mil ; 69(1): 45-49, ene.-mar. 2013.
Article in Spanish | IBECS | ID: ibc-111984
Responsible library: ES1.1
Localization: BNCS
RESUMEN
Se reseñan los medicamentos ya evaluados por la Agencia Española de Medicamentos y Productos Sanitarios hechos públicos en el último trimestre de 2012, y considerados de mayor interés para el profesional sanitario. Se trata de opiniones técnicas positivas que son previas a la autorización y puesta en el mercado del medicamento (AU)
ABSTRACT
The drugs assessed by the Spanish Agency for Medicines and Health Products made public in the last quarter of 2012, and considered of interest to the healthcare professional, are reviewed. These are positive technical reports prior to the authorization and placing on the market of the product (AU)
Subject(s)

Full text: Available Collection: National databases / Spain Database: IBECS Main subject: Reference Drugs Limits: Humans Language: Spanish Journal: Sanid. mil Year: 2013 Document type: Article Institution/Affiliation country: Hospital Central de la Defensa Gómez Ulla/España

Full text: Available Collection: National databases / Spain Database: IBECS Main subject: Reference Drugs Limits: Humans Language: Spanish Journal: Sanid. mil Year: 2013 Document type: Article Institution/Affiliation country: Hospital Central de la Defensa Gómez Ulla/España
...